FindMyKOL
Clinical trialNCT01342510CompletedPhase 4Interventional

Combination of Magnesium and Lidocaine for the Pretreatment of Pain That is Caused by the Injection of Propofol

NCT01342510 is a phase 4 interventional trial sponsored by University of Wisconsin, Madison. As of 18 Nov 2026, it is completed. It studies Control, Lidocaine and Magnesium sulfate in General Anesthesia and Intravenous Anesthesia. The registry lists an enrollment of 200 participants at 1 site in 1 country. The registry lists a start date of 30 Apr 2011 and a primary completion date of 30 Apr 2012.

SponsorUniversity of Wisconsin, MadisonEnrollment200General AnesthesiaIntravenous Anesthesia
View the registry record on ClinicalTrials.gov

Key facts

Registry attributes as recorded on the ClinicalTrials.gov study record.

Key facts for NCT01342510
FieldValue
Registry IDNCT01342510
StatusCompleted
PhasePhase 4
Study typeInterventional trial
Lead sponsorUniversity of Wisconsin, Madison
Enrollment200
Registered sites1
Countries1
ConditionsGeneral Anesthesia and Intravenous Anesthesia
DrugsControl, Lidocaine and Magnesium sulfate
Start30 Apr 2011
Primary completion30 Apr 2012
Study completion30 Apr 2012
Last update posted29 May 2019

Registered summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Since the introduction of propofol into routine anesthesia practice, the phenomena of pain on injection has plagued anesthesia providers. Propofol, an unstable phenol, triggers the release of bradykinin on injection. This release causes a painful burning sensation in the patient at the site of injection. Anesthesia providers have attempted a large number of remedies to prevent this pain on injection. Previously explored ideas include injecting propofol into larger veins, warming of the hand with hot packs, and intravenous pretreatment with numerous other medications. Currently, pretreatment with lidocaine is commonly administered to prevent propofol injection pain. No studies to date have looked at the combination of lidocaine and magnesium in a single syringe for the pretreatment of pain on injection caused by propofol. In addition, the administration protocols that have been studied thus far do not mirror clinical practice at the University of Wisconsin. The investigators propose studying the use of magnesium and lidocaine in a single syringe for pretreatment of propofol related pain on injection.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Wisconsin, United States1 site
  • University of Wisconsin Hospital and Clinics

    Madison

United States, by state

AlaskaAKMaineMEVermontVTNew HampshireNHWashingtonWAMontanaMTNorth DakotaNDMinnesotaMNWisconsin: 1 siteWI1MichiganMINew YorkNYMassachusettsMARhode IslandRIOregonORIdahoIDSouth DakotaSDIowaIAIllinoisILIndianaINOhioOHPennsylvaniaPANew JerseyNJConnecticutCTCaliforniaCANevadaNVWyomingWYNebraskaNEMissouriMOKentuckyKYWest VirginiaWVVirginiaVAMarylandMDDelawareDEArizonaAZUtahUTColoradoCOKansasKSArkansasARTennesseeTNNorth CarolinaNCSouth CarolinaSCNew MexicoNMOklahomaOKLouisianaLAMississippiMSAlabamaALGeorgiaGAHawaiiHITexasTXFloridaFLDistrict of ColumbiaDC
Fewer sitesMore sites

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Questions about NCT01342510

Each answer restates registry values shown on this page.

What is NCT01342510?

NCT01342510 is a phase 4 interventional trial sponsored by University of Wisconsin, Madison. It studies Control, Lidocaine and Magnesium sulfate in General Anesthesia and Intravenous Anesthesia.

Who leads NCT01342510?

The registry names Kristopher M Schroeder, MD (principal investigator, University of Wisconsin, Madison) as the overall official.

Where does NCT01342510 run?

The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.

Which drugs does NCT01342510 study?

The registered drug and biological interventions are Control, Lidocaine and Magnesium sulfate.

When did NCT01342510 end?

The registry lists a primary completion date of 30 Apr 2012 and a study completion date of 30 Apr 2012. The sponsor last updated the record on 29 May 2019.

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 18 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.